Saturn V Capital Management’s 2seventy bio TSVT Stock Holding History
Bought
Maintained
Sold
Other funds holding TSVT
KCM
BBA
O
CC
Saturn V Capital Management's TSVT Position: Q2 2023 in Review
Saturn V Capital Management sold out of 2seventy bio (TSVT) in Q2 2023, closing a stake of 172,188 shares — an estimated $1.76M sold.
Saturn V Capital Management first reported a position in TSVT in Q4 2022 and held it in 2 quarters. The position peaked at $9.89M in Q4 2022. 149 funds tracked by Wall St. Rank hold TSVT as of Q2 2023.
- Saturn V Capital Management reported no remaining 2seventy bio position as of Q2 2023 after selling out during the quarter.
- Saturn V Capital Management sold 172,188 2seventy bio shares in Q2 2023, an estimated $1.76M.
- Saturn V Capital Management first reported a position in 2seventy bio in Q4 2022 and held it in 2 quarters.
- Saturn V Capital Management's 2seventy bio position peaked at $9.89M in Q4 2022.
- 149 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2023.
Based on Saturn V Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.